Effekt der Skalpblockade auf intraoperative Hämodynamik und postoperative Schmerzen bei Kraniotomiepatienten
Wirksamkeit der Skalpblockade auf intraoperative hämodynamische Reaktionen und postoperative Analgesie bei Patienten mit Kraniotomie
The goal of this clinical trial is to learn if an ultrasound-guided scalp block can improve intraoperative hemodynamic stability and provide better postoperative pain relief in adult patients undergoing elective supratentorial craniotomy. The main questions it aims to answer are:
Does ultrasound-guided scalp block reduce changes in heart rate and blood pressure during surgery compared with surgical site infiltration?
Does ultrasound-guided scalp block decrease postoperative pain and opioid requirements in the first 24 hours after craniotomy?
Researchers will compare patients receiving an ultrasound-guided scalp block to those receiving standard surgical site infiltration to see if the scalp block provides better perioperative hemodynamic control and postoperative analgesia.
Participants will:
Receive general anesthesia with either ultrasound-guided scalp block or surgical site infiltration
Have heart rate, blood pressure, and other hemodynamic parameters monitored throughout surgery
Receive standard postoperative pain management, with pain scores recorded at 0, 2, 6, 12, and 24 hours
Receive opioids as needed based on pain scores, with total opioid consumption and time to first analgesic dose recorded
Be monitored for adverse events, including nausea, vomiting, sedation, and block-related complications
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
This clinical trial is designed to evaluate whether an ultrasound-guided scalp block improves outcomes in adult patients undergoing elective craniotomy. Craniotomy, a surgical procedure to access the brain, can be associated with significant pain and stress responses during and after surgery. Painful events such as intubation, placement of skull pins, skin incision, and manipulation of the scalp and dura can cause rapid increases in heart rate and blood pressure, which may be harmful, especially in patients with brain injuries or compromised cerebral blood flow.
Currently, these hemodynamic changes are often managed with general anaesthesia and systemic medications such as opioids. However, opioids can delay recovery, cause nausea and vomiting, and interfere with neurological assessments after surgery. Regional anaesthesia techniques, like a scalp block, can reduce the body's stress response to surgery, provide better pain relief, and decrease the need for systemic pain medications. Ultrasound guidance allows anesthesiologists to locate nerves more accurately and perform the block safely, reducing potential complications.
In this study, participants will be randomly assigned to one of two groups. One group will receive a standard surgical site infiltration with local anaesthetic, while the other group will receive an ultrasound-guided scalp block in addition to general anaesthesia. All participants will be closely monitored during surgery, with measurements of heart rate, blood pressure, and other vital signs taken at key points, including before induction, during intubation, at skull pin placement, at skin incision, and at skin closure.
After surgery, participants will receive routine pain management and will be monitored for the first 24 hours. Pain levels will be recorded at multiple time points, and the total use of opioid pain medications, time to first analgesic, and any side effects or complications will be documented.
The main goal of the study is to determine whether the ultrasound-guided scalp block can provide better control of heart rate and blood pressure during surgery and improve postoperative pain relief compared with surgical site infiltration. Secondary goals include assessing the amount of pain medication needed after surgery and the incidence of any side effects, such as nausea, vomiting, or sedation.
Results from this study may help improve patient comfort, reduce complications, and optimize pain management strategies for patients undergoing brain surgery.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Kazi Mahzabin Arin, MD
- Telefonnummer: +8801754057689
- E-Mail: kazimahzabinarin@bsmmu.edu.bd
Studieren Sie die Kontaktsicherung
- Name: AKM Akhtaruzzaman, MD
- E-Mail: akm.akhtaruzzaman@bmu.ac.bd
Studienorte
-
-
-
Dhaka, Bangladesch, 1000
- Rekrutierung
- Bangladesh Medical University
-
Kontakt:
- Kazi Mahzabin Arin, MD
- Telefonnummer: 01754057689
- E-Mail: kazimahzabinarin@bmu.ac.bd
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age 18-64 years.
- ASA (American Society of Anesthesiologists) physical status I or II.
- Patients scheduled for elective supratentorial craniotomy.
- BMI of 18 to 30 kg/m².
- GCS score of 9 to 15.
Exclusion Criteria:
- Patient with instable blood pressure and heart rate.
- Known allergy or hypersensitivity to local anesthetics.
- Coagulation disorders or current anticoagulant therapy.
- Infection at the injection site or systemic infection.
- Patients with open skull defects.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Aktiver Komparator: Group Surgical site infiltration (SSI)
Participants in this group will receive standard general anesthesia for elective supratentorial craniotomy. In addition, local anesthetic will be administered via surgical site infiltration. |
Participants receiving this intervention will undergo local anesthetic infiltration at the planned surgical sites in addition to standard general anesthesia for elective supratentorial craniotomy. Drug: Bupivacaine 0.5% plain solution Dosage: 10-15 ml along the incision line plus 5 ml at each pin insertion site Dosage Form: Injectable solution Route: Subcutaneous and deep infiltration into the scalp Timing: Single administration immediately after induction of general anesthesia, prior to surgical incision |
|
Experimental: Group Scalp block
Participants in this group will receive standard general anesthesia for elective supratentorial craniotomy. In addition, they will receive an ultrasound-guided scalp block targeting the major nerves of the scalp. |
Participants receiving this intervention will undergo ultrasound-guided regional nerve blockade of the scalp in addition to standard general anesthesia for elective supratentorial craniotomy. The procedure targets the supratrochlear, supraorbital, auriculotemporal, postauricular branches of the greater auricular nerve, and the greater, lesser, and third occipital nerves. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Änderungen der Herzfrequenz (Schläge pro Minute)
Zeitfenster: 1. Baseline 2. Während der Operation (Vor der Einleitung (T0) Nach der Intubation (T1) Nach USB/SSI (T2) Nach dem Einsetzen der Schädelstifte (T3) Während des Hautschnitts (T4) Während der Duraeröffnung (T5) Während des Hautverschlusses (T6))
|
1. Baseline 2. Während der Operation (Vor der Einleitung (T0) Nach der Intubation (T1) Nach USB/SSI (T2) Nach dem Einsetzen der Schädelstifte (T3) Während des Hautschnitts (T4) Während der Duraeröffnung (T5) Während des Hautverschlusses (T6))
|
|
|
Änderung des systolischen Blutdrucks (SBP) (in mmHg)
Zeitfenster: 1. Baseline 2. Während der Operation (Vor der Einleitung (T0) Nach der Intubation (T1) Nach USB/SSI (T2) Nach der Schädelstiftinsertion (T3) Während des Hautschnitts (T4) Während der Duraeröffnung (T5) Während des Hautverschlusses (T6))
|
1. Baseline 2. Während der Operation (Vor der Einleitung (T0) Nach der Intubation (T1) Nach USB/SSI (T2) Nach der Schädelstiftinsertion (T3) Während des Hautschnitts (T4) Während der Duraeröffnung (T5) Während des Hautverschlusses (T6))
|
|
|
Änderung des diastolischen Blutdrucks (DBP) (in mmHg)
Zeitfenster: 1. Basislinie 2. Während der Operation (Vor der Einleitung (T0) Nach der Intubation (T1) Nach USB/SSI (T2) Nach dem Einsetzen der Schädelstifte (T3) Während des Hautschnitts (T4) Während der Duraeröffnung (T5) Während des Hautverschlusses (T6))
|
1. Basislinie 2. Während der Operation (Vor der Einleitung (T0) Nach der Intubation (T1) Nach USB/SSI (T2) Nach dem Einsetzen der Schädelstifte (T3) Während des Hautschnitts (T4) Während der Duraeröffnung (T5) Während des Hautverschlusses (T6))
|
|
|
Veränderung des mittleren arteriellen Drucks (MAP) (in mmHg)
Zeitfenster: 1. Baseline 2. Während der Operation (Vor der Induktion (T0) Nach der Intubation (T1) Nach USB/SSI (T2) Nach dem Einführen des Schädelstifts (T3) Während des Hautschnitts (T4) Während der Duraeröffnung (T5) Während des Hautverschlusses (T6))
|
1. Baseline 2. Während der Operation (Vor der Induktion (T0) Nach der Intubation (T1) Nach USB/SSI (T2) Nach dem Einführen des Schädelstifts (T3) Während des Hautschnitts (T4) Während der Duraeröffnung (T5) Während des Hautverschlusses (T6))
|
|
|
Postoperative pain intensity by Numeric Rating Scale (NRS)
Zeitfenster: Immediately after shifting to the recovery room, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours
|
Scores range from 0 to 10, where 0 represents 'no pain' and 10 represents 'worst possible pain'. High scores indicate more pain. |
Immediately after shifting to the recovery room, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Gesamtverbrauch von Morphin sulfat (mg) in 24 Stunden
Zeitfenster: 24 Stunden
|
24 Stunden
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Paul A, Krishna HM. Comparison between intravenous dexmedetomidine and local lignocaine infiltration to attenuate the haemodynamic response to skull pin head holder application during craniotomy. Indian J Anaesth. 2015 Dec;59(12):785-8. doi: 10.4103/0019-5049.171558.
- Papangelou A, Radzik BR, Smith T, Gottschalk A. A review of scalp blockade for cranial surgery. J Clin Anesth. 2013 Mar;25(2):150-9. doi: 10.1016/j.jclinane.2012.06.024. Epub 2013 Jan 23.
- Guilfoyle MR, Helmy A, Duane D, Hutchinson PJA. Regional scalp block for postcraniotomy analgesia: a systematic review and meta-analysis. Anesth Analg. 2013 May;116(5):1093-1102. doi: 10.1213/ANE.0b013e3182863c22. Epub 2013 Mar 11.
- Pinosky ML, Fishman RL, Reeves ST, Harvey SC, Patel S, Palesch Y, Dorman BH. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996 Dec;83(6):1256-61. doi: 10.1097/00000539-199612000-00022.
- Hans P, Brichant JF, Dewandre PY, Born JD, Lamy M. Effects of two calculated plasma sufentanil concentrations on the hemodynamic and bispectral index responses to Mayfield head holder application. J Neurosurg Anesthesiol. 1999 Apr;11(2):81-5. doi: 10.1097/00008506-199904000-00002.
- Geze S, Yilmaz AA, Tuzuner F. The effect of scalp block and local infiltration on the haemodynamic and stress response to skull-pin placement for craniotomy. Eur J Anaesthesiol. 2009 Apr;26(4):298-303. doi: 10.1097/EJA.0b013e32831aedb2.
- Bharne S, Bidkar PU, Badhe AS, Parida S, Ramesh AS. Comparison of intravenous labetalol and bupivacaine scalp block on the hemodynamic and entropy changes following skull pin application: A randomized, open label clinical trial. Asian J Neurosurg. 2016 Jan-Mar;11(1):60-5. doi: 10.4103/1793-5482.165801.
- Vadivelu N, Kai AM, Tran D, Kodumudi G, Legler A, Ayrian E. Options for perioperative pain management in neurosurgery. J Pain Res. 2016 Feb 10;9:37-47. doi: 10.2147/JPR.S85782. eCollection 2016.
- Can BO, Bilgin H. Effects of scalp block with bupivacaine versus levobupivacaine on haemodynamic response to head pinning and comparative efficacies in postoperative analgesia: A randomized controlled trial. J Int Med Res. 2017 Apr;45(2):439-450. doi: 10.1177/0300060516665752. Epub 2017 Mar 7.
- Misra S, Koshy T, Unnikrishnan KP, Suneel PR, Chatterjee N. Gabapentin premedication decreases the hemodynamic response to skull pin insertion in patients undergoing craniotomy. J Neurosurg Anesthesiol. 2011 Apr;23(2):110-7. doi: 10.1097/ANA.0b013e3181da3c3b.
- Doblar DD, Lim YC, Baykan N, Frenette L. A comparison of alfentanil, esmolol, lidocaine, and thiopental sodium on the hemodynamic response to insertion of headrest skull pins. J Clin Anesth. 1996 Feb;8(1):31-5. doi: 10.1016/0952-8180(95)00169-7.
- Carella M, Tran G, Bonhomme VL, Franssen C. Influence of Levobupivacaine Regional Scalp Block on Hemodynamic Stability, Intra- and Postoperative Opioid Consumption in Supratentorial Craniotomies: A Randomized Controlled Trial. Anesth Analg. 2021 Feb 1;132(2):500-511. doi: 10.1213/ANE.0000000000005230.
- Zetlaoui PJ, Gauthier E, Benhamou D. Ultrasound-guided scalp nerve blocks for neurosurgery: A narrative review. Anaesth Crit Care Pain Med. 2020 Dec;39(6):876-882. doi: 10.1016/j.accpm.2020.06.019. Epub 2020 Oct 8.
- Yildiz K, Bicer C, Aksu R, Dogru K, Madenoglu H, Boyaci A. A comparison of 1 minimum alveolar concentration desflurane and 1 minimum alveolar concentration isoflurane anesthesia in patients undergoing craniotomy for supratentorial lesions. Curr Ther Res Clin Exp. 2011 Apr;72(2):49-59. doi: 10.1016/j.curtheres.2011.03.001.
- Uyar AS, Yagmurdur H, Fidan Y, Topkaya C, Basar H. Dexmedetomidine attenuates the hemodynamic and neuroendocrinal responses to skull-pin head-holder application during craniotomy. J Neurosurg Anesthesiol. 2008 Jul;20(3):174-9. doi: 10.1097/ANA.0b013e318177e5eb.
- Theerth KA, Sriganesh K, Reddy KM, Chakrabarti D, Umamaheswara Rao GS. Analgesia Nociception Index-guided intraoperative fentanyl consumption and postoperative analgesia in patients receiving scalp block versus incision-site infiltration for craniotomy. Minerva Anestesiol. 2018 Dec;84(12):1361-1368. doi: 10.23736/S0375-9393.18.12837-9. Epub 2018 Jul 9.
- Theerth KA, Sriganesh K, Chakrabarti D, Reddy KRM, Rao GSU. Analgesia nociception index and hemodynamic changes during skull pin application for supratentorial craniotomies in patients receiving scalp block versus pin-site infiltration: A randomized controlled trial. Saudi J Anaesth. 2019 Oct-Dec;13(4):306-311. doi: 10.4103/sja.SJA_812_18.
- Nanayakkara D, Manawaratne R, Sampath H, Vadysinghe A, Peiris R. Supraorbital nerve exits: positional variations and localization relative to surgical landmarks. Anat Cell Biol. 2018 Mar;51(1):19-24. doi: 10.5115/acb.2018.51.1.19. Epub 2018 Mar 28.
- Kondavagilu SR, Pujari VS, Chadalawada MV, Bevinguddaiah Y. Low Dose Dexmedetomidine Attenuates Hemodynamic Response to Skull Pin Holder Application. Anesth Essays Res. 2017 Jan-Mar;11(1):57-61. doi: 10.4103/0259-1162.200229.
- Kara AK, Sari S, Tan KB, Topcu A, Donmez N, Turgut M, Aydin ON. Efficacy of selective scalp nerve blocks for postoperative pain in craniotomy: A single-center experience. Agri. 2025 Oct;37(4):240-242. doi: 10.14744/agri.2023.93708.
- Kamal MM, Chowdhury IH, Islam MI, Hossain MJ, Akhtaruzzaman AK. Effect of Intravenous Paracetamol with Bupivacaine Scalp Nerve Block on Haemodynamics Response as Well as Anaesthetic Requirements during Supratentorial Craniotomies. Mymensingh Med J. 2020 Apr;29(2):341-350.
- Fu PH, Teng IC, Liu WC, Chen IW, Ho CN, Hsing CH, Sun CK, Hung KC. Association of scalp block with intraoperative hemodynamic profiles and postoperative pain outcomes at 24-48 hours following craniotomy: An updated systematic review and meta-analysis of randomized controlled studies. Pain Pract. 2023 Feb;23(2):136-144. doi: 10.1111/papr.13167. Epub 2022 Oct 6.
- Arshad A, Shamim MS, Waqas M, Enam H, Enam SA. How effective is the local anesthetic infiltration of pin sites prior to application of head clamps: A prospective observational cohort study of hemodynamic response in patients undergoing elective craniotomy. Surg Neurol Int. 2013 Jul 18;4:93. doi: 10.4103/2152-7806.115237. eCollection 2013.
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- #6026
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .